The Global Health and Vaccination Research Program (GLOBVAC) has recently announced a global health funding opportunity that will give priority to research on family planning as well as maternal, neonatal, and child health. The group has announced up to NOK 244 million for research in these areas. From the Research Council of Norway:
Family planning, reproductive, maternal, neonatal, child and youth health are relevant topics for the new priority. All relevant health aspects are covered, including nutrition and child development. An important aspect is the follow-up of the recommendations of the UN Commission on Life-Saving Commodities for Women and Children. Encourage collaboration with low and middle-income countries International collaboration is highly encouraged in the call. Collaborations and partnerships with highly qualified international groups, including partnerships with research groups and institutions in low and middle-income countries are strongly encouraged. Relevance for the health-related United Nations Millennium Development Goals, i.e. child and maternal health and communicable diseases, as well as other major global health endeavours, is of overarching importance to GLOBVAC. Priorities for this call: 1. Prevention and treatment of, and diagnostics for, communicable diseases with particular relevance for low and lower-middle income countries. 2. Prevention and treatment of, and diagnostics for, neglected tropical diseases. 3. Family planning, reproductive, maternal, neonatal, child and youth health. 4. Health systems and health policy research. 5. Implementation research. 6. Innovation in technology and methods development for maternal and child health in settings where appropriate technologies are not available or non-existing. The application deadline is 4 September 2013.
Learn more about this opportunity.